Intraabdominal hypertension (IAH) is associated with significant morbidity and mortality in surgical and trauma patients. The aim of this study was to assess, in a mixed population of critically ill patients, whether intraabdominal pressure (IAP) at admission was an independent predictor for mortality and to evaluate the effects of IAH on organ functions.
Design
A multiple-center, prospective, epidemiological study consisting of a total of 265 consecutive patients admitted for greater than 24 hours to 14 intensive care units in 6 countries over a 4 week study period.
Methods
IAP was measured twice daily via a Foley bladder catheter according to the modified Kron technique. IAP was measured in the complete supine position and under stable conditions according to a standardized protocol. Patients were excluded in they had contra-indications for intra-vesical pressure measurement. Data recorded on admission were the patient demographics with Simplified Acute Physiology Score (SAPS) II, Acute Physiology and Chronic Health Evaluation (APACHE) II score, and type of admission. Sepsis-Related Organ Failure Assessment (SOFA) score and IAP were measured daily along with fluid balance.
Results
Non-survivors had a significantly higher mean IAP on admission than survivors (11.4 ± 4.8 vs. 9.5 ± 4.8mmHg, p=0.002). Other independent predictors for mortality were age, APACHE II score, diagnostic category of intensive care unit admission (medical vs. surgical), the presence of liver dysfunction and the occurrence of IAH during the intensive care stay. Patients with IAH on admission had significantly higher SOFA scores during the intensive care stay than those without. IAH was defined as IAP>12mmHg and abdominal compartment syndrome (ACS) as IAP>20mmHg + ≥1 organ failure.
Conclusions
The development of IAH on intensive care is an independent risk factor for mortality. IAH on admission is associated with severe organ dysfunction
Are the results in the study valid? PRIMARY GUIDES

Was there a representative and well defined sample of patients at a similar point in the course of the disease?
All patients admitted in January 2001 to 14 different ICUs were included with no patients meeting inclusion criteria "missed". If true, this eliminates selection bias and makes the cohort a representative sample. By definition, intensive care patients are a diverse group at different points in their disease process but the observations were made at predefined times.
Was follow up sufficiently long and complete?
The patients were followed until death, hospital discharge or 28 days. Patients transferred to another hospital or ICU were no longer followed although the number of such transfers is unclear. The authors do state that 28-day outcome was included if known, but do not say what was assumed if unknown. However, there do not appear to be any missing patients from the data. 28-day mortality is a well accepted time frame.
SECONDARY GUIDES
Were objective and unbiased outcome criteria used? Yes, the primary outcome was mortality.
Was there adjustment for important prognostic factors?
Yes, other independent mortality predictors were calculated using a logistic regression model. These were; age, APACHE II scores, type of ICU admission and liver dysfunction. When the patients were subdivided into groups based on APACHE II 1. quartiles; IAH conferred a significantly increased 1. relative mortality risk for the first three quartiles. The relative risk increase was however non-significant for the fourth quartile (APACHE II > 22).
What are the results?
How large is the likelihood of the outcome event(s) in a specified period of time? 28 day mortality was significantly higher in the IAH group (38.8% vs 22.2%, p=0.05) and the incidence of IAH was 32.1%. The occurrence of IAH during admission increases the relative risk of death by 1.85 (95% CI, 1.12-3.06)
Will the results help in caring for my patients?
Were the study patients similar to my own? This is not clear; the study is multicentre and international, but the control mortality is high. APACHE risk of death scores are not stated.
Will the results lead directly to selecting or avoiding therapy?
It is not yet known if IAH causes death; how to best treat it; and if mortality falls with treatment. However, the development of IAH on intensive care may prompt a search for a cause and possible treatment.
Are the results useful for reassuring/counselling patients?
IAP is unlikely to be the only information being used by the clinician during discussions with patients/ families. It is more likely to be useful as evidence of a worsening prognosis in critically ill patients.
Comment
1. This was a straightforward short, sharp study with clearly defined measurements and end points.
2. This study also only used data obtained in the first week for statistical purposes. Given that they found development of IAH to be an independent predictor of mortality, it might be interesting to know how many patients developed IAH after 7 days and what their outcome was.
3. This paper agrees with previous studies in surgical and trauma patients which have found that elevated IAP was associated with increased mortality. Organ dysfunction scores currently used to predict outcome do not include IAP.
4. The results may be influenced by the threshold value of 12mmHg to define IAH which is arbitrary.
The study of ACS is new and still poorly understood.
5. Although non survivors had higher mean IAPs on admission; there is not a great deal of difference between 9 Vs 11mmHg considering that the standard errors were relatively wide. Despite the finding of significance, the clinical relevance of this finding could be questioned.
6. We are not told the error of the measuring equipment or inter-operator variability, which would allow more critical interpretation of the results.
7. The mention of the use of abdominal perfusion pressure as an endpoint to guide treatment may provide more scope for intervention.
8. There does appear to be an error in the results section of the paper. They state that 140 patients (67.9%) had a normal IAP on admission. This should read 180 patients.
Conclusion
The study was not designed with intervention based on threshold values for IAP. Nevertheless, the idea of maintaining an abdominal perfusion pressure in an analogous way to cerebral perfusion pressure is tantalizing. Further research is needed to investigate whether this could be used to guide treatment as a resuscitation endpoint in addition to using oxygen-derived variables or markers of end organ function.
It is not yet clear if IAP should be used in outcome measurement scores for intensive care.
